Key result
Sacubitril-valsartan and SGLT2 inhibitors show promise for pediatric HF but require more pediatric-specific data.
Why the study?
Pediatric heart failure management has historically relied on adult trials and expert consensus, but responses vary by etiology and pediatric-specific data for newer therapies remain limited.
This review summarizes the current state and evolution of medical therapies for pediatric heart failure, emphasizing the need for pediatric-specific data for newer agents.
Should not yet alter standard pediatric HF care; leaves open the promise of newer agents for future investigation.
Pediatric heart failure is a rare but serious condition affecting children with congenital heart disease and various forms of cardiomyopathy. The treatment paradigm for pediatric heart failure has historically been shaped by expert consensus guidelines, largely informed by the results of adult heart failure trials. Recently, however, there has been an increased focus on pediatric-specific drug development and clinical trials. Medications such as digoxin, beta-blockers, and renin-angiotensin-aldosterone system inhibitors have been explored in children, but responses can vary based on the underlying heart disease. Newer treatments such as sacubitril-valsartan and sodium-glucose cotransporter 2 inhibitors show promise, but more data are needed to determine their safety and efficacy in young children. This article explores the current state of medical therapy for chronic pediatric heart failure, highlighting the evolution of treatment strategies and the novel therapies under exploration.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2025) conducted a review in Pediatric heart failure. Medical therapies (e.g., sacubitril-valsartan, SGLT2 inhibitors) was evaluated. Medical therapies for pediatric heart failure are evolving, with newer treatments like sacubitril-valsartan and SGLT2 inhibitors showing promise, though more pediatric-specific data are needed.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: